Health
Novel Combinations Excite the R/R Hodgkin Lymphoma Treatment Landscape – Targeted Oncology
While the treatment of relapsed or refractory Hodgkin lymphoma has seen novel approaches in recent years improving outcomes for many patients, high-risk patients…
While the treatment of relapsed or refractory (R/R) Hodgkin lymphoma (HL) has seen novel approaches in recent years improving outcomes for many patients, high-risk patients develop progressive disease and have limited treatment options.1
Two studies presented during the 62nd American Society of Hematology Annual Meeting and Exposition explored new therapeutic strategies for this patient population. First, results from a phase 2 study (NCT04052997) suggest that camidanlumab tesirine (ADCT-301) can…
-
General22 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
General20 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News24 hours agoBrisbane bands unite to help bassist’s cancer fight
-
Noosa News15 hours agoThe Laundry Lady secures $1M to fuel international expansion